|4Feb 4, 4:40 PM ET

BRYCE RICHARD PAUL 4

4 · Rain Therapeutics Inc. · Filed Feb 4, 2022

Insider Transaction Report

Form 4
Period: 2022-01-07
BRYCE RICHARD PAUL
Chief Medical Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-01-07+53,06453,064 total
    Exercise: $12.01Exp: 2032-01-07Common Stock (53,064 underlying)
Footnotes (1)
  • [F1]This option represents a right to purchase a total of 53,064 shares of the Issuer's common stock, one quarter of which will vest on January 7, 2023, with the remaining three quarters vesting in equal monthly installments through January 7, 2026, subject to the Reporting Person's continued service to the Issuer.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION